These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23857878)
1. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study. Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1222-32. PubMed ID: 23857878 [TBL] [Abstract][Full Text] [Related]
2. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883 [TBL] [Abstract][Full Text] [Related]
3. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation. Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131 [TBL] [Abstract][Full Text] [Related]
5. Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Warnier MJ; Rutten FH; Souverein PC; de Boer A; Hoes AW; De Bruin ML Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):701-8. PubMed ID: 26013175 [TBL] [Abstract][Full Text] [Related]
6. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
7. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation. Milic M; Bao X; Rizos D; Liu F; Ziegler MG Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469 [TBL] [Abstract][Full Text] [Related]
8. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Charbit B; Alvarez JC; Dasque E; Abe E; Démolis JL; Funck-Brentano C Anesthesiology; 2008 Aug; 109(2):206-12. PubMed ID: 18648229 [TBL] [Abstract][Full Text] [Related]
9. Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort. Coughtrie AL; Behr ER; Layton D; Marshall V; Camm AJ; Shakir SAW BMJ Open; 2017 Oct; 7(10):e016627. PubMed ID: 29042382 [TBL] [Abstract][Full Text] [Related]
10. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects]. van de Loo A; Klingenheben T; Hohnloser SH Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927 [TBL] [Abstract][Full Text] [Related]
11. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and Risk Factors of Drug-Associated Corrected QT Prolongation in Elderly Hospitalized Patients: Results of a Retrospective Analysis of Data Obtained Over 6 Months. Maison O; de la Gastine B; Dayot L; Goutelle S Drugs Aging; 2017 Jul; 34(7):545-553. PubMed ID: 28577045 [TBL] [Abstract][Full Text] [Related]
13. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation. Malik M; Hnatkova K; Batchvarov V Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536 [TBL] [Abstract][Full Text] [Related]
14. Effect of myocardial ischemia and type I antiarrhythmic drug therapy on exercise QT intervals. Gardner MJ; McCarthy DM; Josephson ME Can J Cardiol; 1985 Jan; 1(1):37-40. PubMed ID: 3850762 [TBL] [Abstract][Full Text] [Related]
15. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435 [TBL] [Abstract][Full Text] [Related]
16. Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population. Yun J; Hwangbo E; Lee J; Chon CR; Kim PA; Jeong IH; Park M; Park R; Kang SJ; Choi D Cardiovasc Toxicol; 2015 Apr; 15(2):197-202. PubMed ID: 25253561 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction. Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for QTc interval prolongation. Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918 [TBL] [Abstract][Full Text] [Related]
19. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227 [TBL] [Abstract][Full Text] [Related]
20. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Takahara A; Sugiyama A; Hashimoto K Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]